Assembly Biosciences (ASMB) Accumulated Expenses (2011 - 2021)

Assembly Biosciences' Accumulated Expenses history runs 11 years deep, the most recent figure standing at $3.7 million for Q3 2021.

• In Q3 2021, Accumulated Expenses fell 15.88% year-over-year to $3.7 million; the TTM figure through Sep 2021 stood at $3.7 million (down 15.88% YoY), while the FY2020 annual figure was $4.4 million, down 16.34% from the prior year.
• Accumulated Expenses for Q3 2021 stood at $3.7 million, up from $3.7 million in the prior quarter.
• The five-year high for Accumulated Expenses was $10.1 million in Q1 2019, with the low at $2.8 million in Q2 2019.
• The 5-year median for Accumulated Expenses is $4.5 million (2020), against an average of $5.2 million.
• The sharpest annual moves came in 2017 and 2020: Accumulated Expenses jumped 222.84% in 2017, then slumped 54.31% in 2020.
• Assembly Biosciences' Accumulated Expenses stood at $6.4 million in 2017, then retreated by 26.84% to $4.6 million in 2018, then climbed by 14.3% to $5.3 million in 2019, then fell by 16.34% to $4.4 million in 2020, then fell by 15.75% to $3.7 million in 2021.
• Business Quant data shows ASMB's Accumulated Expenses at $3.7 million in Q3 2021, $3.7 million in Q2 2021, and $4.3 million in Q1 2021.